San Diego-dependent Viking Therapeutics marked itself as a serious competitor in the weight loss drug marketplace in February right after revealing promising information from a mid-stage demo of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when supplied for a weekly injection As well as in March the co